Literature DB >> 22428909

Low rate of sustained virological response in an outbreak of acute hepatitis C in HIV-infected patients.

Montserrat Laguno1, Maria Martínez-Rebollar, Iñaki Perez, Josep Costa, Maria Larrousse, Marta Calvo, Montse Loncá, Ana Muñoz, Ana González-Cordón, José Luís Blanco, Esteban Martínez, Josep Maria Gatell, Josep Mallolas.   

Abstract

Recent reports have suggested an increased risk of acute hepatitis C (AHC) infection in homosexual HIV-infected men and that early treatment with interferon-alfa, alone or associated with ribavirin, significantly reduces the risk of chronic evolution. A retrospective analysis of 38 HIV-infected patients who were consecutively diagnosed as developing AHC, defined by both seroconversion of anti-hepatitis C virus (HCV) antibodies and detection of serum HCV-RNA in those with previous negative results. Thirty-six patients were men with history of unprotected sexual intercourse with men and two were women with sexual and nosocomial risk factors. AHC infection was asymptomatic in 26 patients; asthenia and jaundice were the most frequent symptoms. HCV genotype 1 was present in 19 patients and genotype 4 in 14 patients. Thirty-five patients received early antiviral treatment with pegylated interferon-alfa associated with ribavirin; 15 of the 32 patients who completed the follow-up (47%) achieved a sustained virological response, as defined by undetectable HCV-RNA 6 months after the end of therapy. There is a risk of sexual transmission of HCV in HIV-infected men who have sex with men. In our experience, early treatment of AHC with pegylated interferon-alfa plus ribavirin in HIV patients achieves poor results.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428909     DOI: 10.1089/AID.2011.0289

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.

Authors:  Christoph Boesecke; Patrick Ingiliz; Thomas Reiberger; Hans-Jürgen Stellbrink; Sanjay Bhagani; Emma Page; Stefan Mauss; Thomas Lutz; Esther Voigt; Marguerite Guiguet; Marc-Antoine Valantin; Axel Baumgarten; Mark Nelson; Martin Vogel; Jürgen K Rockstroh
Journal:  Infection       Date:  2016-02       Impact factor: 3.553

2.  Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure.

Authors:  Mattias Mandorfer; Sebastian Steiner; Philipp Schwabl; Berit A Payer; Maximilian C Aichelburg; Katharina Grabmeier-Pfistershammer; Michael Trauner; Thomas Reiberger; Markus Peck-Radosavljevic
Journal:  Wien Klin Wochenschr       Date:  2015-12-10       Impact factor: 1.704

Review 3.  Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.

Authors:  Bing Zhang; Nghia H Nguyen; Brittany E Yee; Benjamin Yip; Walid S Ayoub; Glen A Lutchman; Mindie H Nguyen
Journal:  Intervirology       Date:  2015-09-25       Impact factor: 1.763

4.  Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013.

Authors:  Gilles Wandeler; Marion Schlauri; Marie-Eve Jaquier; Janine Rohrbach; Karin J Metzner; Jan Fehr; Juan Ambrosioni; Matthias Cavassini; Marcel Stöckle; Patrick Schmid; Enos Bernasconi; Olivia Keiser; Luisa Salazar-Vizcaya; Hansjakob Furrer; Andri Rauch; V Aubert; M Battegay; E Bernasconi; J Böni; H C Bucher; C Burton-Jeangros; A Calmy; M Cavassini; G Dollenmaier; M Egger; L Elzi; J Fehr; J Fellay; H Furrer; C A Fux; M Gorgievski; H Günthard; D Haerry; B Hasse; H H Hirsch; M Hoffmann; I Hösli; C Kahlert; L Kaiser; O Keiser; T Klimkait; R Kouyos; H Kovari; B Ledergerber; G Martinetti; B Martinez de Tejada; K Metzner; N Müller; D Nadal; D Nicca; G Pantaleo; A Rauch; S Regenass; M Rickenbach; C Rudin; F Schöni-Affolter; P Schmid; J Schüpbach; R Speck; P Tarr; A Telenti; A Trkola; P Vernazza; R Weber; S Yerly
Journal:  Open Forum Infect Dis       Date:  2015-03-25       Impact factor: 3.835

5.  Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions.

Authors:  Paz Sobrino-Vegas; Susana Monge Corella; Sergio Serrano-Villar; Félix Gutiérrez; José Ramón Blanco; Ignacio Santos; Jorge del Romero; Ferrán Segura; Joaquín Portilla; Santiago Moreno Guillén; Julia del Amo
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.